Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 120 participants.

Also called NCT04542148

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04542148
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT04542148. Randomized; no masking; primary purpose treatment. Start 2022-02-10 (actual); primary completion 2025-11-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
Condition
Diabetes Mellitus, Type 2
Condition
Preterm Birth
Condition
Pregnancy, High Risk
Condition
Diabetes, Gestational
Intervention (Drug)
Sliding Scale Insulin
Intervention (Drug)
Up-Titration of Home Insulin
Intervention (Drug)
Continuous Insulin Infusion
Intervention (Device)
Dexcom G6 Professional Continuous Glucose Monitor
Lead sponsor
University of Alabama at Birmingham (class: other)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct04542148
Content hash
d98b247df787c6bc013286755f21cd0de95310f61c9584c672a6c1dad36f140f